Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus

Daniel Q Holland, Joshua J NeumillerDepartment of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USAAbstract: Alogliptin is a selective dipeptidyl peptidase-4 inhibitor recently marketed for once-daily administration in the treatment of type 2 diabetes melli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Holl, DQ, Neumiller JJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/53402642e95245d494c8940a9115b18a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!